Suchergebnisse - "Cardiovascular Diseases/mortality [MeSH]"

  • Treffer 1 - 17 von 17
Treffer weiter einschränken
  1. 1
  2. 2
  3. 3

    Quelle: J Epidemiol Glob Health
    Journal of Epidemiology and Global Health, Vol 14, Iss 2, Pp 337-348 (2024)

    Dateibeschreibung: application/pdf

  4. 4
  5. 5

    Quelle: BMC Cardiovasc Disord
    BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-11 (2024)

  6. 6
  7. 7

    Quelle: BMC Public Health
    BMC Public Health, Vol 24, Iss 1, Pp 1-10 (2024)

  8. 8

    Quelle: BMC Cardiovasc Disord
    BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-12 (2024)

  9. 9

    Quelle: Cardiovasc Diabetol
    Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-11 (2024)
    Cardiovascular Diabetology

    Schlagwörter: Male, Blood Glucose, Time Factors, name=Internal Medicine, Risk Assessment, Body Mass Index, BMI variability, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Diseases of the circulatory (Cardiovascular) system, Humans, Diabetes management, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Type 2 diabetes, Aged [MeSH], Risk Assessment [MeSH], Cardiovascular disease, Cardiovascular Diseases/diagnosis [MeSH], Risk Factors [MeSH], Diabetes Mellitus, Type 2/mortality [MeSH], Randomized Controlled Trials as Topic [MeSH], 3P-MACE risk, HbA1c variability, Heart Disease Risk Factors [MeSH], Male [MeSH], Health outcomes, Cardiovascular Diseases/mortality [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Diabetes Mellitus, Type 2/diagnosis [MeSH], Female [MeSH], Diabetes Mellitus, Type 2/complications [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Cardiovascular Diseases/epidemiology [MeSH], Middle Aged [MeSH], Diabetes Mellitus, Type 2/blood [MeSH], Time Factors [MeSH], Body Mass Index [MeSH], Glycated Hemoglobin/metabolism [MeSH], Research, Blood Glucose/metabolism [MeSH], Blood Glucose/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors, Aged, Randomized Controlled Trials as Topic, Glycated Hemoglobin, Middle Aged, 3. Good health, Diabetes and Metabolism, Treatment Outcome, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Heart Disease Risk Factors, RC666-701, Female, name=Endocrinology, Biomarkers, name=Cardiology and Cardiovascular Medicine

    Dateibeschreibung: application/pdf

  10. 10
  11. 11

    Quelle: Clin Res Cardiol
    Clinical Research in Cardiology

    Dateibeschreibung: application/pdf

  12. 12

    Quelle: Cardiovasc Diabetol
    Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-11 (2021)
    Cardiovasc. Diabetol. 20:168 (2021)

    Dateibeschreibung: application/pdf

  13. 13
  14. 14
  15. 15

    Quelle: Cardiovasc Diabetol
    Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-13 (2021)
    Cardiovasc. Diabetol. 20:223 (2021)
    Cardiovascular Diabetology

    Schlagwörter: Male, Time Factors, Endocrinology and Diabetes, MORGAM (MONICA Risk Genetics Archiving and Monograph), Risk Assessment, Biomarkers, Aged [MeSH], Risk Assessment [MeSH], Cardiovascular Diseases/diagnosis [MeSH], Cardiovascular risk, Diabetes Mellitus/epidemiology [MeSH], Original Investigation, Heart Disease Risk Factors [MeSH], Mortality, Male [MeSH], Glycated Hemoglobin A/analysis [MeSH], Diabetes Mellitus/blood [MeSH], Diabetes Mellitus/diagnosis [MeSH], Cardiovascular Diseases/mortality [MeSH], Glycated hemoglobin A, Female [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Cardiovascular Diseases/epidemiology [MeSH], Incidence [MeSH], Middle Aged [MeSH], Time Factors [MeSH], BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe), Europe/epidemiology [MeSH], Prognosis [MeSH], 03 medical and health sciences, 0302 clinical medicine, Kardiologi och kardiovaskulära sjukdomar, Diabetes Mellitus, Diseases of the circulatory (Cardiovascular) system, Humans, Aged, Glycated Hemoglobin, VDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin, sosialmedisin: 801, Glycated hemoglobin A1c (HbA1c), Incidence, Biomarcare (biomarker For Cardiovascular Risk Assessment In Europe), Cardiovascular Risk, Glycated Hemoglobin A (hba ) 1c 1c, Morgam (monica Risk Genetics Archiving And Monograph), Middle Aged, Prognosis, 16. Peace & justice, ddc, 3. Good health, Europe, Cardiovascular Diseases, Heart Disease Risk Factors, RC666-701, Endokrinologi och diabetes, Female, VDP::Medical disciplines: 700::Health sciences: 800::Community medicine, Social medicine: 801, Cardiology and Cardiovascular Disease

    Dateibeschreibung: application/pdf

  16. 16

    Quelle: BMC Med
    BMC Medicine
    r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
    Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
    r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
    instname
    BMC Medicine, Vol 18, Iss 1, Pp 1-13 (2020)
    BiomarCaRE consortium 2020, 'Contribution of cystatin C-and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project', BMC Medicine, vol. 18, no. 1, 300. https://doi.org/10.1186/s12916-020-01776-7
    Rothenbacher, D, Rehm, M, Iacoviello, L, Costanzo, S, Tunstall-Pedoe, H, Belch, J J F, Söderberg, S, Hultdin, J, Salomaa, V, Jousilahti, P, Linneberg, A, Sans, S, Padró, T, Thorand, B, Meisinger, C, Kee, F, McKnight, A J, Palosaari, T, Kuulasmaa, K, Waldeyer, C, Zeller, T, Blankenberg, S, Koenig, W & on behalf of the BiomarCaRE consortium 2020, ' Contribution of cystatin C-and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts : the BiomarCaRE project ', BMC Medicine, vol. 18, no. 1, 300 . https://doi.org/10.1186/s12916-020-01776-7
    BMC Med. 18:300 (2020)

    Dateibeschreibung: application/pdf

  17. 17

    Quelle: BMC Public Health
    BMC Public Health, Vol 20, Iss 1, Pp 1-8 (2020)